Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
CRISPR Therapeutics
CRSP
$4.73B
| $2.33M | ﹤0.01% |
57,384
-46,985
| -45% | -$2.49M |
|
2677
CAE Inc. Common Shares
CAE
$8.3B
| $2.33M | ﹤0.01% |
+89,009
| New | +$1.71M |
|
|
AOD
2678
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
| $2.32M | ﹤0.01% |
297,784
+173,372
| +139% | +$1.34M |
|
2679
WisdomTree
WT
$2.96B
| $2.32M | ﹤0.01% |
425,813
-66,379
| -13% | -$345K |
|
2680
Marcus Corp
MCS
$897M
| $2.31M | ﹤0.01% |
160,825
+54,667
| +51% | +$828K |
|
2681
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.33B
| $2.31M | ﹤0.01% |
36,169
+16,306
| +82% | +$1.05M |
|
|
FFC
2682
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$777M
| $2.3M | ﹤0.01% |
153,280
-136,689
| -47% | -$2.08M |
|
2683
Elastic
ESTC
$6.84B
| $2.3M | ﹤0.01% |
44,580
-13,729
| -24% | -$823K |
|
|
JAMF
2684
DELISTED
Jamf
JAMF
| $2.28M | ﹤0.01% |
107,178
-12,330
| -10% | -$271K |
|
2685
National Presto Industries
NPK
$870M
| $2.28M | ﹤0.01% |
33,329
-3,334
| -9% | -$228K |
|
2686
FIGS
FIGS
$1.79B
| $2.28M | ﹤0.01% |
338,992
+111,822
| +49% | +$804K |
|
2687
Cohen & Steers REIT and Preferred and Income Fund
RNP
$982M
| $2.28M | ﹤0.01% |
112,047
+5,554
| +5% | +$118K |
|
2688
CEVA Inc
CEVA
$910M
| $2.28M | ﹤0.01% |
89,143
-3,885
| -4% | -$105K |
|
2689
Thryv Holdings
THRY
$180M
| $2.27M | ﹤0.01% |
119,572
-2,617
| -2% | -$51.1K |
|
|
EVV
2690
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
| $2.25M | ﹤0.01% |
239,735
-58,706
| -20% | -$567K |
|
|
HA
2691
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.22M | ﹤0.01% |
216,122
-9,974
| -4% | -$133K |
|
|
EMD
2692
Western Asset Emerging Markets Debt Fund
EMD
$609M
| $2.22M | ﹤0.01% |
243,251
+635
| +0.3% | +$5.43K |
|
|
NHS
2693
Neuberger High Yield Strategies Fund Inc
NHS
$251M
| $2.21M | ﹤0.01% |
259,932
+53,912
| +26% | +$452K |
|
|
HAYN
2694
DELISTED
Haynes International, Inc.
HAYN
| $2.21M | ﹤0.01% |
48,443
-1,825
| -4% | -$85.7K |
|
2695
First Trust Nasdaq Bank ETF
FTXO
$305M
| $2.21M | ﹤0.01% |
84,293
-1,603
| -2% | -$43.7K |
|
2696
Grid Dynamics Holdings
GDYN
$559M
| $2.21M | ﹤0.01% |
196,907
-41,522
| -17% | -$539K |
|
|
HPS
2697
John Hancock Preferred Income Fund III
HPS
$457M
| $2.21M | ﹤0.01% |
153,297
-13,619
| -8% | -$198K |
|
2698
ProShares Investment Grade-Interest Rate Hedged
IGHG
$330M
| $2.2M | ﹤0.01% |
30,893
-5,470
| -15% | -$383K |
|
2699
MidCap Financial Investment
MFIC
$787M
| $2.19M | ﹤0.01% |
192,376
+8,515
| +5% | +$98.1K |
|
2700
Treace Medical Concepts
TMCI
$280M
| $2.19M | ﹤0.01% |
+95,308
| New | +$2.19M |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.